http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Evoke Pharma gets patent approval extending GIMOTI protection to 2036
-
MDA Space achieves satellite beam forming milestone with Aurora technology
-
Evoke Pharma Receives Notice of Allowance for U.S. Patent Application for GIMOTI Extending Orange Book listings to 2036
-
MDA SPACE ACHIEVES AN INDUSTRY FIRST IN SATELLITE DIGITAL BEAM FORMING WITH MDA AURORA™
-
Stratasys Celebrates 10 Years of the Fortus 450mc 3D Printer With Launch of Factory-Floor-Ready Additive Manufacturing Solution
-
Foresight: Eye-Net, in Collaboration with Orange’s Mobile Application, Achieves 99% Detection Rate in French Urban Mobility Trials
-
Bitget Integrates xStocks to Bring Wall Street to Web3 with Tokenized Stocks on Onchain
-
BlackRock Launches Industry’s First S&P 500 ex Top 100 ETF for More Precise U.S. Large-cap Exposure
-
Gregory FCA Launches CrisisCalm: The First AI-Powered Crisis Communications Platform
-
Visium Technologies and Investor Hub Co. Ltd Sign Strategic MOU to Advance AI‑Powered Healthcare Solutions Across West Africa
-
Gilead Finalizes Agreement With the Global Fund to Accelerate Access to Twice-Yearly Lenacapavir for HIV Prevention for up to Two Million People in Primarily Low- and Lower-Middle-Income Countries
-
Lightbridge Announces Participation in Upcoming Industry and Investor Events
-
New DJI Power 1000 V2 Increases Stable Power Output for a Smarter, More Efficient Experience
-
4BIO Capital co-leads Actithera’s oversubscribed $75.5 million Series A financing
-
FluidForm Bio™ Presents Six-Month Efficacy Data of FRESH 3D Bioprinted Human Islet Subcutaneous Scaffolds at the American Diabetes Association (ADA) 85th Scientific Sessions
-
Altimmune begins phase 2 trial for pemvidutide in liver disease
-
Bitdeer joins Russell 2000 and 3000 indexes, boosts mining hashrate 21%
-
Altimmune Announces Initiation of RESTORE Phase 2 Trial Evaluating the Efficacy and Safety of Pemvidutide in Alcohol-Associated Liver Disease (ALD)
-
Realbotix to Exhibit at IFA Berlin 2025
-
Bitdeer Announces June 2025 Production and Operations Update
-
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2025 Financial Results
-
Class 1 Nickel Commences 2025 Exploration Program at the River Valley PGE-Cu-Ni Project, Ontario, Canada
-
Krystal Biotech doses first patient in KB801 eye drop gene therapy trial
-
BTCS raises funding target to $225 million for Ethereum purchases
-
BTCS Inc. Further Increases Target Funding to $225 Million for Strategic Ethereum Purchases Using DeFi/TradFi Flywheel
-
Krystal Biotech Announces First Patient Dosed in Phase 1/2 Trial of KB801 for the Treatment of Neurotrophic Keratitis
-
REV. FRANK BOSTIC, KBS ENTERTAINMENT, FRUIT BELT UNITED & TALENT ROOM ENTERTAINMENT will Host the 5th Annual PILGRIM FAMILY FEST and Community Unity Event August 1-3, 2025
-
PreveCeutical Announces Rescheduled Date for Annual General and Special Meeting
-
LunarBet Opens $LUNR Token Presale to Disrupt Crypto iGaming with Real Token Utility
-
Consumers Energy Infrastructure Investments Power Growth and Energize Communities
-
Bitget Lists Tanssi (TANSSI) for Spot Trading with 8,878,000 in Token Rewards
-
Merck to acquire Verona Pharma for $10 billion to add COPD treatment
-
GFG Receives C$200,000 Grant from the Ontario Junior Exploration Program
-
Merck to Acquire Verona Pharma, Expanding its Portfolio to Include Ohtuvayre® (ensifentrine), a First-In-Class COPD Maintenance Treatment for Adults and Expected to Drive Growth into the Next Decade
-
Meridian Drills Copper Dominated Layers of Ore Grading 28.6m @ 3.5 g/t AuEq (2.6% CuEq) at Cabacal
-
Chamberlain University and SSM Health Launch Landmark Partnership to Address Nursing Shortage
-
The MasterFrame 600, Cooler Master's Modular Full Tower for High-End Builds, Now Available in Europe
-
Actithera Raises $75.5M in Oversubscribed Series A Financing to Redefine Precision Radioligand Therapy
-
4BIO Capital co-leads Actithera’s oversubscribed $75.5 million Series A financing
-
Riveting True Story About One Widow's Extraordinary Perseverance and Fight to Prove an Egregious Veteran's Administration Error
-
X removes posts by Musk chatbot Grok after antisemitism complaints
-
Digital Cloud Training Revolutionizes Cloud Education with Job-Focused, Affordable Alternatives to Traditional IT Degrees
-
Lerner and Rowe Hosts Annual Backpack Giveaway in North Las Vegas at Mojave High School to Hand Out 750 Free Backpacks with School Supplies to Benefit Financially Vulnerable Clark County Students
-
Mercy Medical Center Earns Women's Choice Award for Best Hospital in Multiple Areas of Care
-
ROSEN, A LONGSTANDING LAW FIRM, Encourages Sarepta Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SRPT
-
1847 Holdings transitions to OTCQB market after NYSE American delisting
-
1847 Holdings Initiates Transition to OTCQB Market Following NYSE American Delisting Decision
-
Calamos Announces Upside Cap Rates with Defined Downside Protection for Bitcoin Protection ETFs
-
DV DEADLINE: ROSEN, LEADING INVESTOR RIGHTS COUNSEL, Encourages DoubleVerify Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Act
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RCKT
